(NP (NP (NN Objective)) (: :) (S (NP (NP (DT The) (JJ main) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ diagnostic) (NNS performances)) (PP (IN of) (NP (NP (DT an) (NN alert) (NN system)) (VP (VBN integrated) (PP (IN into) (NP (DT the) (NNP CPOE/EMR) (NN system)))) (PP (IN for) (NP (ADJP (RB renally) (VBN cleared)) (NN drug) (VBG dosing) (NN control))))))))))) (. .))
(S (NP (DT The) (JJ generated) (NNS alerts)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ daily) (JJ routine) (NN practice)) (PP (IN of) (NP (NNS pharmacists))))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NN medication) (NNS orders))))))))) (. .))
(NP (NP (NNS Materials) (CC and) (NNS Methods)) (: :) (S (NP (DT The) (NNS pharmacists)) (VP (VP (VBD performed) (NP (NP (PRP$ their) (NN analysis)) (PP (IN of) (NP (NN medication) (NNS orders)))) (PP (IN as) (ADJP (JJ usual)))) (CC and) (VP (VBD were) (RB not) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN alert) (NN system) (NNS interventions)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (RB not) (VP (VBN displayed) (PP (IN for) (NP (NP (DT the) (NN purpose)) (PP (IN of) (NP (DT the) (NN study))))) (PP (DT neither) (PP (TO to) (NP (DT the) (JJ physician))) (CC nor) (PP (TO to) (NP (DT the) (NN pharmacist))))) (CC but) (VP (VBD kept) (PP (IN with) (NP (JJ associate) (NNS recommendations))) (PP (IN in) (NP (DT a) (NN log) (NN file)))))))))))))) (. .))
(S (NP (DT A) (JJ senior) (NN pharmacist)) (VP (VBD analyzed) (NP (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NN medication) (NN order) (NN analysis)))) (PP (IN with) (CC and) (IN without) (NP (DT the) (NN alert) (NN system))))) (. .))
(S (NP (NP (DT The) (NN unit)) (PP (IN of) (NP (NN analysis)))) (VP (VBD was) (NP (DT the) (NN drug) (NN prescription) (NN line))) (. .))
(S (NP (DT The) (JJ primary) (NN study) (NNS endpoints)) (VP (VBD were) (NP (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ drug-dose) (NN prescription) (NNS errors)))) (CC and) (NP (NP (JJ inter-rater) (NN reliability)) (PP (IN between) (NP (NP (DT the) (NN alert) (NN system)) (CC and) (NP (DT the) (NNS pharmacists)))) (PP (IN in) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN drug) (NN dose) (NN error)))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (S (NP (DT The) (NN alert) (NN system)) (VP (VBD fired) (NP (NNS alerts)) (PP (IN in) (NP (NP (CD 8.41) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 421/5006)) (-RRB- -RRB-)) (PP (IN of) (NP (NNS cases))))))) (: :) (S (S (NP (NP (CD 5.65) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 283/5006)) (-RRB- -RRB-))) (VP (NNS exceeds) (NP (VBP max) (RB daily) (JJ dose) (NNS alerts)))) (CC and) (S (NP (NP (CD 2.76) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 138/5006)) (-RRB- -RRB-))) (PP (IN under) (NP (NN dose) (NNS alerts)))))) (. .))
(S (NP (NP (DT The) (NN alert) (NN system)) (CC and) (NP (DT the) (NNS pharmacists))) (VP (VBD showed) (NP (NP (DT a) (ADJP (RB relatively) (JJ poor)) (NN concordance)) (: :) (NP (NP (CD 0.106)) (PRN (-LRB- -LRB-) (NP (NP (NNP CI)) (CD 95) (NN %)) (PRN (JJ -LSB-) (NP (NP (CD 0.068)) (, ,) (CD 0.144)) (NN -RSB-)) (-RRB- -RRB-))))) (. .))
(S (PP (VBG According) (PP (TO to) (NP (DT the) (JJ senior) (NN pharmacist) (NN review)))) (, ,) (NP (DT the) (NN alert) (NN system)) (VP (VP (VBD fired) (NP (NP (ADJP (RBR more) (JJ appropriate)) (NNS alerts)) (PP (IN than) (NP (NNS pharmacists))))) (, ,) (CC and) (VP (VBD made) (NP (NP (NP (JJR fewer) (NNS errors)) (PP (IN than) (NP (NNS pharmacists))) (PP (IN in) (S (VP (VBG analyzing) (NP (NN drug) (JJ dose) (NNS prescriptions)))))) (: :) (NP (NP (NP (CD 143)) (PP (IN for) (NP (DT the) (NN alert) (NN system)))) (CC and) (NP (NP (CD 261)) (PP (IN for) (NP (DT the) (NNS pharmacists)))))))) (. .))
(S (PP (IN Unlike) (NP (DT the) (NN alert) (NN system))) (, ,) (NP (NP (RBS most) (JJ diagnostic) (NNS errors)) (VP (VBN made) (PP (IN by) (NP (DT the) (NNS pharmacists))))) (VP (VBD were) (NP (JJ false) (NNS negatives))) (. .))
(S (NP (DT The) (NNS pharmacists)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB analyze) (NP (NP (NP (DT a) (JJ significant) (NN number)) (PRN (-LRB- -LRB-) (NP (NP (CD 2097)) (: ;) (NP (CD 25.42) (NN %))) (-RRB- -RRB-))) (PP (IN of) (NP (NN drug) (NN prescription) (NNS lines)))))))) (PP (IN because) (NP (NN understaffing)))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (NP (DT This) (NN study)) (VP (ADVP (RB strongly)) (VBZ suggests) (SBAR (IN that) (S (NP (DT an) (NN alert) (NN system)) (VP (MD would) (VP (VP (VB be) (ADJP (JJ complementary) (PP (TO to) (NP (DT the) (NNS pharmacists) (NN activity))))) (CC and) (VP (NN contribute) (PP (TO to) (NP (NN drug) (NN prescription) (NN safety)))))))))) (. .))
